Drug Cos. Using REMS to Delay Generic Competition
Five years ago in the wake of the Vioxx scandal, Congress passed…
Mobile Health Around the Globe: Sweden – The Virtual Pharmacist
In recent times the market for over-the-counter drugs was demonopolized in…
Pharma: Funding R&D: High Prices, Overuse A Failed Strategy
Much has been written about the travails of the pharmaceutical industry. Generic…
What is ePrescribing?
ePrescribing(Electronic prescribing ) is the computer-based electronic generation, transmission and filling of…
Health Literacy Resources for Pharmacies
The AHRQ has released resources to help hospitals address Pharmacy Health Literacy; the…
Questions for FDA, NIH on Failure to Publish Clinical Trial Data
Hat tip to FDAWebview: Three leading Democratic Congressmen are wondering why companies…
Counterfeit Avastin Cancer Drugs Found in the US
Most of the doctors who bought it were in California too, where…
Social Media: Pharma Industry Considers Patient Engagement a Must
The Pharmaceutical industry feels patient engagement is a priority, but…
Avastin for Colon Cancer: A Conflicted View
In the long-running war to hold down health care spending, controlling cancer…
Yanking Avastin’s Breast Cancer Indication –the Right Thing To Do
As expected the FDA today removed Avastin’s approval for use as a…
